Recently, The Procter & Gamble Company announced first-quarter results for fiscal year 2026, reporting net sales of $22.4 billion, up 3% year-on-year. Organic sales, excluding foreign exchange and portfolio impacts, rose 2%, driven by 1% higher pricing and a 1% favorable mix, while volume remained flat.
Net earnings for the quarter totaled $4.8 billion, with diluted net earnings per share increasing 21% to $1.95, largely reflecting higher non-core restructuring charges in the prior year. Core EPS rose 3% to $1.99, and operating cash flow reached $5.4 billion.
“Our organic sales growth, earnings and cash results in the first quarter reflect strong execution of our integrated strategy,” said Jon Moeller, Chairman, President and CEO. “We are increasing investment in innovation and demand creation to deliver superior value to consumers and drive category growth.”
Across categories, P&G’s Beauty segment led performance with net sales of $4.1 billion, up 6 yoy. Hair Care rose in the low single digits, supported by volume gains and innovation-led pricing in North America and Europe. Personal Care saw high single-digit growth driven by strong innovation and pricing, while Skin Care advanced mid-single digits on favorable premium mix and pricing, despite softer volumes.
The Grooming segment recorded $1.8 billion in net sales, up 5% yoy, driven by innovation-led pricing and steady demand in North America and Europe. Health Care grew 1%, as stable Oral Care performance and modest Personal Health Care gains in Latin America and North America were offset by volume declines.
Looking ahead, P&G reaffirmed its fiscal 2026 guidance, expecting all-in sales growth of 1% to 5% and organic sales growth of flat to +4%. The company projects diluted net EPS growth of 3% to 9% and core EPS growth of flat to +4%, corresponding to $6.83–$7.09 per share, with a midpoint estimate of $6.96.
